BRAND_ANALYSIS #ROCHE HEALTH & PHARMA #18 OF 26 IN HEALTH & PHARMA ALIGNED

Roche

· Private · Updated 09 Jul 2026 08:27 UTC
#612 of 1208 overall by tension · #18 of 26 in Health & Pharma
13 Aligned
The Balanced
Analysis

Pharma giant: C=57/B=70 with 0.70 sentiment suggests healthcare companies have recovered reputation lost in the pandemic. Roche's drug portfolio speaks louder than any corporate narrative ever could.

IN THE NEWS (100 articles this week)
Inflammatory bowel diseases - Roche
Roche orchestrates phase 3 lung cancer win over Amgen and BMS - Fierce Biotech
Roche KRAS drug succeeds in head-to-head lung cancer study - BioPharma Dive
Cultural Score
57 / 100
Business Score
70 / 100
TENSION▁▁▁▁▁▁▁▁▁▁▂▂▂▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▅▅▅▅▅▅▅▅▅▆▆▆▅
Loading...
Wikipedia Momentum 15/40
News Presence 43/35
Search InterestRedistributed to other dimensions
Stock Momentum 0/30
Market Position 0/25
Revenue Growth 0/25
Earnings Health 0/20
Roche's tension is 13. Commerce outpacing culture. sociologyofcapitalism.com/brand/roche
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/roche.html" width="320" height="200" frameborder="0"></iframe>